Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
British Journal of Cancer|September 29, 2005
Strong expression of ID1 protein is associated with decreased survival, increased expression of ephrin-A1/EPHA2, and reduced thrombospondin-1 in malignant melanomaO Straume, L A AkslenCancer|September 15, 1996
Independent prognostic importance of vascular invasion in nodular melanomasO Straume, L A AkslenInternational Journal of Cancer|November 14, 1997
Alterations and prognostic significance of p16 and p53 protein expression in subgroups of cutaneous melanomaO Straume, L A AkslenThe American Journal of Pathology|July 5, 2001
Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomasO Straume, L A AkslenClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanomaO Straume, L Sviland, L A AkslenAnticancer Research|February 24, 2001
Frequent loss of p16 protein expression and high proliferative activity (Ki-67) in malignant melanoma from black AfricansE Vuhahula, O Straume, L A AkslenInternational Journal of Oncology|July 31, 1999
Angiogenesis is prognostically important in vertical growth phase melanomasO Straume, H B Salvesen, L A AkslenProceedings of the National Academy of Sciences of the United States of America|April 21, 2022
Climate transition at the Eocene-Oligocene influenced by bathymetric changes to the Atlantic-Arctic oceanic gatewaysEivind O Straume, Aleksi Nummelin, Carmen Gaina, et al.International Journal of Cancer|March 12, 1998
Frequent mutations of the p53 gene in cutaneous melanoma of the nodular typeL A Akslen, S E Monstad, B Larsen, et al.International Journal of Cancer|October 23, 2001
A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rareR Kumar, J Smeds, P Berggren, et al.Pageof 2